Literature DB >> 23836567

Use of qPCR and genomic sequencing to diagnose Plasmodium ovale wallikeri malaria in a returned soldier in the setting of a negative rapid diagnostic assay.

Robert Cohen1, Karla Feghali, Saba Alemayehu, Jack Komisar, Jun Hang, Peter J Weina, Patricia Coggeshall, Edwin Kamau, Michael Zapor.   

Abstract

Plasmodium ovale is one of several clinically relevant malaria species known to cause disease in humans. However, in contrast to Plasmodium falciparum and Plasmodium vivax, which are responsible for most cases of human malaria, P. ovale has a wide distribution but low prevalence in tropical regions. Here, we report the case of a soldier returning from Liberia with P. ovale wallikeri malaria. This case highlights the limitations of both microscopy and the malaria rapid diagnostic test for diagnosing infection with P. ovale and for distinguishing P. ovale wallikeri from P. ovale curtisi. To our knowledge, this is the first case report in which quantitative real-time polymerase chain reaction amplification using the Cytochrome B gene, coupled with genomic sequencing of the potra locus, was used for definitive diagnosis of P. ovale wallikeri malaria.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23836567      PMCID: PMC3771289          DOI: 10.4269/ajtmh.12-0724

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  17 in total

1.  Development of a highly sensitive genus-specific quantitative reverse transcriptase real-time PCR assay for detection and quantitation of plasmodium by amplifying RNA and DNA of the 18S rRNA genes.

Authors:  Edwin Kamau; Ladonna S Tolbert; Luke Kortepeter; Michael Pratt; Nancy Nyakoe; Linda Muringo; Bernard Ogutu; John N Waitumbi; Christian F Ockenhouse
Journal:  J Clin Microbiol       Date:  2011-06-08       Impact factor: 5.948

2.  Evaluation of the Immunoquick+4 malaria rapid diagnostic test in a non-endemic setting.

Authors:  D P J van Dijk; P Gillet; E Vlieghe; L Cnops; M Van Esbroeck; J Jacobs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-03-16       Impact factor: 3.267

3.  How prevalent are Plasmodium ovale and P. malariae in East Asia?

Authors:  F Kawamoto; Q Liu; M U Ferreira; I S Tantular
Journal:  Parasitol Today       Date:  1999-10

4.  Multiplex real-time PCR detection of P. falciparum, P. vivax and P. malariae in human blood samples.

Authors:  Vincent Veron; Stephane Simon; Bernard Carme
Journal:  Exp Parasitol       Date:  2008-12-25       Impact factor: 2.011

5.  Evaluation of the Binax NOW ICT test versus polymerase chain reaction and microscopy for the detection of malaria in returned travelers.

Authors:  Gabriella A Farcas; Kathleen J Y Zhong; Fiona E Lovegrove; Christopher M Graham; Kevin C Kain
Journal:  Am J Trop Med Hyg       Date:  2003-12       Impact factor: 2.345

6.  Diagnostic criteria and risk factors for Plasmodium ovale malaria.

Authors:  Farba B K Faye; André Spiegel; Adama Tall; Cheikh Sokhna; Didier Fontenille; Christophe Rogier; Jean-François Trape
Journal:  J Infect Dis       Date:  2002-08-01       Impact factor: 5.226

7.  Evaluation of the rapid diagnostic test CareStart pLDH Malaria (Pf-pLDH/pan-pLDH) for the diagnosis of malaria in a reference setting.

Authors:  Marloes Heutmekers; Philippe Gillet; Jessica Maltha; Annelies Scheirlinck; Lieselotte Cnops; Emmanuel Bottieau; Marjan Van Esbroeck; Jan Jacobs
Journal:  Malar J       Date:  2012-06-18       Impact factor: 2.979

8.  Plasmodium ovale curtisi and Plasmodium ovale wallikeri circulate simultaneously in African communities.

Authors:  Mary Chiaka Oguike; Martha Betson; Martina Burke; Debbie Nolder; J Russell Stothard; Immo Kleinschmidt; Carla Proietti; Teun Bousema; Mathieu Ndounga; Kazuyuki Tanabe; Edward Ntege; Richard Culleton; Colin J Sutherland
Journal:  Int J Parasitol       Date:  2011-02-23       Impact factor: 3.981

9.  Evaluation of the Clearview® Malaria pLDH Malaria Rapid Diagnostic Test in a non-endemic setting.

Authors:  Sandrine Houzé; Véronique Hubert; Dorit Pessler Cohen; Baruch Rivetz; Jacques Le Bras
Journal:  Malar J       Date:  2011-09-27       Impact factor: 2.979

10.  Development, validation and evaluation of a rapid PCR-nucleic acid lateral flow immuno-assay for the detection of Plasmodium and the differentiation between Plasmodium falciparum and Plasmodium vivax.

Authors:  Petra F Mens; Antoine P H A Moers; Laura M de Bes; Jonathan Flint; Jathee R S Sak; Lily Keereecharoen; Chantal van Overmeir; Jaco J Verweij; Rachel L Hallett; Benchawan Wihokhoen; Stephane Proux; Henk D F H Schallig; Aart van Amerongen
Journal:  Malar J       Date:  2012-08-17       Impact factor: 2.979

View more
  5 in total

1.  Sequence-based optimization of a quantitative real-time PCR assay for detection of Plasmodium ovale and Plasmodium malariae.

Authors:  Melissa Phuong; Rachel Lau; Filip Ralevski; Andrea K Boggild
Journal:  J Clin Microbiol       Date:  2014-01-15       Impact factor: 5.948

Review 2.  Recent advances in detection of Plasmodium ovale: implications of separation into the two species Plasmodium ovale wallikeri and Plasmodium ovale curtisi.

Authors:  Hans-Peter Fuehrer; Harald Noedl
Journal:  J Clin Microbiol       Date:  2013-10-23       Impact factor: 5.948

3.  Characterization of Plasmodium ovale curtisi and P. ovale wallikeri in Western Kenya utilizing a novel species-specific real-time PCR assay.

Authors:  Robin H Miller; Clifford O Obuya; Elizabeth W Wanja; Bernhards Ogutu; John Waitumbi; Shirley Luckhart; V Ann Stewart
Journal:  PLoS Negl Trop Dis       Date:  2015-01-15

4.  Molecular diagnosis of Plasmodium ovale by photo-induced electron transfer fluorogenic primers: PET-PCR.

Authors:  David Akerele; Dragan Ljolje; Eldin Talundzic; Venkatachalam Udhayakumar; Naomi W Lucchi
Journal:  PLoS One       Date:  2017-06-22       Impact factor: 3.240

5.  A comparison of two PCR protocols for the differentiation of Plasmodium ovale species and implications for clinical management in travellers returning to Germany: a 10-year cross-sectional study.

Authors:  Hagen Frickmann; Christine Wegner; Stefanie Ruben; Ulrike Loderstädt; Egbert Tannich
Journal:  Malar J       Date:  2019-08-09       Impact factor: 2.979

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.